News

European regulatory authorities have finalized their assessment of reported non-compliance with Good Manufacturing Practice (GMP) at Toansa site that had led to the suspension of the GMP certificate

FDA’s Fast Track program facilitates the development and review of drugs intended to treat serious conditions and fill an unmet medical need. A drug development program with Fast

Currently, Isentress film-coated tablets are administered twice daily in accordance with the approved Prescribing Information. Isentress is an integrase inhibitor indicated in combination with other antiretroviral (ARV) agents

The solution is an alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. The company said that phenylephrine possesses predominantly

As part of the deal, arGEN-X will bring its entire suite of human antibody discovery technologies to a partnership focused on multiple targets aligned with Shire’s therapeutic focus.

The new solution helps life sciences companies enhance efficiency of clinical trial processes by driving greater collaboration between pharmaceutical companies and contract research organizations (CROs). This solution helps

This manufacturing facility supplements Glenmark’s existing in-house discovery and development capabilities and will supply material for clinical development. Glenmark Pharmaceuticals’ Swiss research center is an integrated antibody discovery

TPG Biotech previously invested $12.8 million in the Company, and along with the Company’s angel investors, has financed the Company since inception. The Company plans to use the

The allowed patent claims contain both composition and method of treatment claims that will broadly cover all of InSite’s bromfenac product candidates, including BromSite ((bromfenac 0.075%) ophthalmic solution